Michael H. Wilson

Array ( [id] => 6736024 [patent_doc_number] => 20030013659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Halovir, an antiviral marine natural product, and derivatives thereof' [patent_app_type] => new [patent_app_number] => 10/217234 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5056 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013659.pdf [firstpage_image] =>[orig_patent_app_number] => 10217234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150829 [patent_doc_number] => 20040171534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'GRF analogs with increased biological potency' [patent_app_type] => new [patent_app_number] => 10/212883 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14841 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171534.pdf [firstpage_image] =>[orig_patent_app_number] => 10212883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601665 [patent_doc_number] => 07385037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Method for the preparation of gliadin- and glutenin-rich fractions out of gluten in an aqueous medium and in the presence of an acid' [patent_app_type] => utility [patent_app_number] => 10/485884 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3232 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/385/07385037.pdf [firstpage_image] =>[orig_patent_app_number] => 10485884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7627184 [patent_doc_number] => 06807258 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Method and system for billing remote calls as if made from a primary line' [patent_app_type] => B1 [patent_app_number] => 10/205292 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6881 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/807/06807258.pdf [firstpage_image] =>[orig_patent_app_number] => 10205292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870543 [patent_doc_number] => 20030083233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Methods and compositions for optimization of oxygen transport by cell-free systems' [patent_app_type] => new [patent_app_number] => 10/199269 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 39821 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083233.pdf [firstpage_image] =>[orig_patent_app_number] => 10199269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7451480 [patent_doc_number] => 20040010122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Process for producing insoluble and soluble collagen protein products from poultry skins and use thereof' [patent_app_type] => new [patent_app_number] => 10/195193 [patent_app_country] => US [patent_app_date] => 2002-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4502 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010122.pdf [firstpage_image] =>[orig_patent_app_number] => 10195193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 785331 [patent_doc_number] => 06989366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-24 [patent_title] => 'Exendins, exendin agonists, and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/187051 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 37293 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989366.pdf [firstpage_image] =>[orig_patent_app_number] => 10187051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745634 [patent_doc_number] => 20030022817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementation and an energy supplement containing such an additive' [patent_app_type] => new [patent_app_number] => 10/166036 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022817.pdf [firstpage_image] =>[orig_patent_app_number] => 10166036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905059 [patent_doc_number] => 20020142010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Method and compositions for the treatment of cerebral palsy' [patent_app_type] => new [patent_app_number] => 10/155280 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142010.pdf [firstpage_image] =>[orig_patent_app_number] => 10155280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745865 [patent_doc_number] => 20030023048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => ' Chemical modification of proteins to improve biocompatibility and bioactivity' [patent_app_type] => new [patent_app_number] => 10/140464 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6465 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023048.pdf [firstpage_image] =>[orig_patent_app_number] => 10140464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783701 [patent_doc_number] => 20030065149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Stabilized hemoglobin solutions' [patent_app_type] => new [patent_app_number] => 10/124941 [patent_app_country] => US [patent_app_date] => 2002-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11390 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065149.pdf [firstpage_image] =>[orig_patent_app_number] => 10124941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953971 [patent_doc_number] => 06958385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Bioactive peptides, uses thereof and process for the production of same' [patent_app_type] => utility [patent_app_number] => 10/122286 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958385.pdf [firstpage_image] =>[orig_patent_app_number] => 10122286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6406621 [patent_doc_number] => 20020182705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Method for increasing the serum half-life of a biologically active molecule' [patent_app_type] => new [patent_app_number] => 10/123092 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6657 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182705.pdf [firstpage_image] =>[orig_patent_app_number] => 10123092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 490452 [patent_doc_number] => 07214768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-08 [patent_title] => 'Echinocandin process' [patent_app_type] => utility [patent_app_number] => 10/474893 [patent_app_country] => US [patent_app_date] => 2002-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2987 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214768.pdf [firstpage_image] =>[orig_patent_app_number] => 10474893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730702 [patent_doc_number] => 20030186892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Enhancement of endogenous gonadotropin production' [patent_app_type] => new [patent_app_number] => 10/063197 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3496 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186892.pdf [firstpage_image] =>[orig_patent_app_number] => 10063197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745649 [patent_doc_number] => 20030022832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for the production of gelatin of marine origin and product thus obtained' [patent_app_type] => new [patent_app_number] => 10/108272 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 988 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022832.pdf [firstpage_image] =>[orig_patent_app_number] => 10108272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015060 [patent_doc_number] => 20020102275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Methods and compositions for the treatment of cerebral palsy' [patent_app_type] => new [patent_app_number] => 10/104899 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3563 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102275.pdf [firstpage_image] =>[orig_patent_app_number] => 10104899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6570971 [patent_doc_number] => 20020165366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Method for purifying FSH' [patent_app_type] => new [patent_app_number] => 10/104194 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11691 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165366.pdf [firstpage_image] =>[orig_patent_app_number] => 10104194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6415494 [patent_doc_number] => 20020183489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Large scale production of low fat and SDS gel pure kappa-casein glycomacropeptides (GMP) from bovine deproteinzed whey' [patent_app_type] => new [patent_app_number] => 10/099612 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2802 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183489.pdf [firstpage_image] =>[orig_patent_app_number] => 10099612 [rel_patent_id] =>[rel_patent_doc_number] =>)